Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 2 |
2023 | 2 |
2024 | 4 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Comparison of the measurement properties of the EQ-5D-5L and SF-6Dv2 among overweight and obesity populations in China.
Health Qual Life Outcomes. 2023 Oct 31;21(1):118. doi: 10.1186/s12955-023-02202-1.
Health Qual Life Outcomes. 2023.
PMID: 37904216
Free PMC article.
Population Norms for SF-6Dv2 and EQ-5D-5L in China.
Xie S, Wu J, Xie F.
Xie S, et al.
Appl Health Econ Health Policy. 2022 Jul;20(4):573-585. doi: 10.1007/s40258-022-00715-2. Epub 2022 Feb 8.
Appl Health Econ Health Policy. 2022.
PMID: 35132573
Item in Clipboard
Validation of the Generic Version of China Health Related Outcomes Measures (CHROME-G) among individuals with type 2 diabetes in China.
Li M, Xie S, Yang M, Wu Y, Li Z, Li R, Li X, Li X, Liu Y, Wu J, Zhao K, Xie F, Yang K.
Li M, et al.
J Evid Based Med. 2024 Sep 24. doi: 10.1111/jebm.12642. Online ahead of print.
J Evid Based Med. 2024.
PMID: 39314139
Item in Clipboard
Mapping IWQOL-Lite onto EQ-5D-5L and SF-6Dv2 among overweight and obese population in China.
Guo W, Xie S, Wang D, Wu J.
Guo W, et al.
Qual Life Res. 2024 Mar;33(3):817-829. doi: 10.1007/s11136-023-03568-x. Epub 2024 Jan 3.
Qual Life Res. 2024.
PMID: 38167749
Item in Clipboard
Discrete choice experiment with duration versus time trade-off: a comparison of test-retest reliability of health utility elicitation approaches in SF-6Dv2 valuation.
Xie S, Wu J, Chen G.
Xie S, et al.
Qual Life Res. 2022 Sep;31(9):2791-2803. doi: 10.1007/s11136-022-03159-2. Epub 2022 May 25.
Qual Life Res. 2022.
PMID: 35610406
Item in Clipboard
Comparative performance and mapping algorithms between EQ-5D-5L and SF-6Dv2 among the Chinese general population.
Xie S, Wu J, Chen G.
Xie S, et al.
Eur J Health Econ. 2024 Feb;25(1):7-19. doi: 10.1007/s10198-023-01566-x. Epub 2023 Jan 29.
Eur J Health Econ. 2024.
PMID: 36709458
Item in Clipboard
Evaluating the Preferences and Willingness-to-Pay for Oral Antidiabetic Drugs Among Patients with Type 2 Diabetes Mellitus in China: A Discrete Choice Experiment.
Chuang LH, Zhang H, Hong T, Xie S.
Chuang LH, et al.
Patient. 2024 Sep;17(5):565-574. doi: 10.1007/s40271-024-00694-7. Epub 2024 Apr 20.
Patient. 2024.
PMID: 38642244
Item in Clipboard
Cite
Cite